Americans prioritize medication prices

In addition to electing a new president, U.S. voters would like to see the price of prescription drugs come down, according to a survey that the Alliance of Minority Medical Associations has conducted. According to the survey, affordability of medicines is a top priority of 47 percent of respondents. Less than a quarter of respondents said that ease of access to doctors, clinics and hospitals was a second priority for them.

Americans are also supportive of more rapid approvals of generic medications and biotechnology add-ons for current drugs, the survey found.

- see this article from the Pharmaceutical Business Review

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.